Mark E. Strome - Jan 17, 2025 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
10%+ Owner
Signature
/s/ Mark E. Strome
Stock symbol
ZIVO
Transactions as of
Jan 17, 2025
Transactions value $
$629,000
Form type
4
Date filed
1/21/2025, 08:00 AM
Previous filing
Jan 23, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIVO Common Stock Other $629K +34K +8.53% $18.50 433K Jan 17, 2025 By entity F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are owned directly by Strome Mezzanine Fund, LP ("SMF"). On January 17, 2025, SMF entered into an Exchange Agreement with the Issuer, pursuant to which in exchange for cancelling the License Co-Development Participation Agreement between the Issuer and SMF dated October 8, 2020, the Issuer agreed to issue to SMF the reported securities.
F2 Strome Investment Management, LP is the general partner of SMF. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act").
F3 Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.